0001193125-20-073017 Sample Contracts

HARPOON THERAPEUTICS, INC., Issuer AND [TRUSTEE], Trustee INDENTURE Dated as of [●], 20 Debt Securities
Indenture • March 13th, 2020 • Harpoon Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York

INDENTURE, dated as of [●], 20__, among HARPOON THERAPEUTICS, INC., a Delaware corporation (the “Company”), and [TRUSTEE], as trustee (the “Trustee”):

Sample 1Sample 2Sample 3See All (487)
AutoNDA by SimpleDocs
Harpoon Therapeutics, Inc. Shares of Common Stock (par value $0.0001 per share) Controlled Equity OfferingSM Sales Agreement
Sales Agreement • March 13th, 2020 • Harpoon Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York

Harpoon Therapeutics, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co. (the “Agent”), as follows:

Sample 1Sample 2Sample 3See All (324)
HARPOON THERAPEUTICS, INC. AND ________, AS WARRANT AGENT FORM OF COMMON STOCK WARRANT AGREEMENT DATED AS OF ____________
Common Stock Warrant Agreement • March 13th, 2020 • Harpoon Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York

THIS COMMON STOCK WARRANT AGREEMENT (this “Agreement”), dated as of between HARPOON THERAPEUTICS, INC., a Delaware corporation (the “Company”) and , a [corporation] [national banking association] organized and existing under the laws of and having a corporate trust office in , as warrant agent (the “Warrant Agent”).

Sample 1Sample 2Sample 3See All (266)
HARPOON THERAPEUTICS, INC. AND ________, AS WARRANT AGENT FORM OF DEBT SECURITIES WARRANT AGREEMENT DATED AS OF ______________
Warrant Agreement • March 13th, 2020 • Harpoon Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York

THIS DEBT SECURITIES WARRANT AGREEMENT (this “Agreement”), dated as of between HARPOON THERAPEUTICS, INC., a Delaware corporation (the “Company”) and , a [corporation] [national banking association] organized and existing under the laws of and having a corporate trust office in , as warrant agent (the “Warrant Agent”).

Sample 1Sample 2Sample 3See All (241)
HARPOON THERAPEUTICS, INC. AND ________, AS WARRANT AGENT FORM OF PREFERRED STOCK WARRANT AGREEMENT DATED AS OF ___________
Preferred Stock Warrant Agreement • March 13th, 2020 • Harpoon Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York

THIS PREFERRED STOCK WARRANT AGREEMENT (this “Agreement”), dated as of between HARPOON THERAPEUTICS, INC., a Delaware corporation (the “Company”) and , a [corporation] [national banking association] organized and existing under the laws of and having a corporate trust office in , as warrant agent (the “Warrant Agent”).

Sample 1Sample 2Sample 3See All (199)
Time is Money Join Law Insider Premium to draft better contracts faster.